Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Burgel, Pierre Régis ^a   Paillasseur, Jean Louis ^b   Peene, Bernard ^c   Dusser, Daniel ^a   Roche, Nicolas ^d   Coolen, Johan ^c   Troosters, Thierry ^c   Decramer, Marc ^c   Janssens, Wim ^c  

^a AP HP and Université Paris Descartes Sorbonne Paris Cité ^*  (France)

^b Clindatafirst   (France)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLUSTER ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERINFLATION; LOW RISK POPULATION; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PATIENT CODING; PATIENT IDENTIFICATION; PHENOTYPE; RESPIRATORY AIRFLOW; RISK ASSESSMENT; SPIROMETRY; SURVIVAL TIME;

AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SURVIVAL RATE;

EID: 84870902536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051048     Document Type: Article

References (20)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555.
2. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, et al. (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11: 122.
3. Sin DD, Anthonisen NR, Soriano JB, Agusti AG, (2006) Mortality in COPD: role of comorbidities. Eur Resp J 28: 1245-1257.
4. Dolan S, Varkey B, (2005) Prognostic factors in chronic obstructive pulmonary disease. Curr Opin Pulm Med 11: 149-152.
5. Agusti A, Celli B, (2011) Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation. Eur Resp J 38: 749-751.
6. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, et al. (2010) Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182: 598-604.
7. Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R, (2005) Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 35: 1254-1262.
8. Fingleton J, Weatherall M, Beasley R, (2011) Towards individualised treatment in COPD. Thorax 66: 363-364.
9. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, et al. (2009) Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Resp J 34: 812-818.
10. Weatherall M, Shirtcliffe P, Travers J, Beasley R, (2010) Use of cluster analysis to define COPD phenotypes. Eur Respir J 36: 472-474.
11. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, et al. (2010) Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 36: 531-539.
12. Garcia-Aymerich J, Gomez FP, Benet M, Farrero E, Basagana X, et al. (2011) Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 66: 430-437.
13. van Iersel CA, de Koning HJ, Draisma G, Mali WPTM, Scholten ET, et al. (2006) Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120: 868-874.
14. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, et al. (2003) Development, validity and responsiveness of the clinical COPD questionnaire. Health Qual Life Outcomes 1: 13.
15. National Emphysema Treatment Trial Research Group (2001) Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 345: 1075-1083.
16. Lambrechts D, Buysschaert I, Zanen P, Coolen J, Lays N, et al. (2010) The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pumonary disease is associated with emphysema. Am J Respir Crit Care Med 181: 486-493.
17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, et al. (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16: 5-40.
18. Foreman MG, Zhang L, Murphy J, Hansel NN, Make B, et al. (2011) Early-Onset Chronic Obstructive Pulmonary Disease Is Associated with Female Sex, Maternal Factors, and African American Race in the COPDGene Study. Am J Respir Crit Care Med 184: 414-420.
19. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, et al. (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60: 925-931.
20. Rutten FH, Cramer MJM, Grobbee DE, Sachs APE, Kirkels JH, et al. (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 26: 1887-1894.